UK NHS and Google DeepMind AI identifies unknown antibiotic resistance in 48 hours
Updated
Updated · WIRED · Apr 29
UK NHS and Google DeepMind AI identifies unknown antibiotic resistance in 48 hours
7 articles · Updated · WIRED · Apr 29
The AI system, developed with Imperial College London, uncovered resistance mechanisms in days that previously took a decade to solve, achieving over 99% diagnostic accuracy.
Rapid AI-powered diagnostics can inform urgent treatment decisions, especially for life-threatening infections like sepsis, and are crucial for rural and high-resistance regions.
Experts warn that economic barriers hinder new antibiotic development, prompting the UK and Sweden to pilot subscription-based payment models to incentivize pharmaceutical innovation against rising global resistance.
We have the tech to fight superbugs, but do we have the political will to win?
Is our focus on new drugs ignoring the 70% of antibiotics used in agriculture?
Can 'Netflix-style' payment models truly provide a sustainable, long-term fix for antibiotic development?
Is the UN's goal of a 10% death reduction by 2030 ambitious enough to stop the superbug threat?
How can we prevent AI from worsening health inequity if its data comes from wealthy nations?
Are robotic bacteria cleaners a viable future or a distraction from fixing the antibiotic pipeline?